Evan Sussman
Evan Sussman is a Chief Executive Officer at Granata Bio.
JournalAdvancing fertility therapeutics: Scientific, clinical and regulatory challenges in assisted reproduction
This article examines the evolution of fertility therapeutics from urinary-derived gonadotropins to recombinant biologics, and the scientific and operational challenges of fertility drug development. It discusses emerging opportunities across the reproductive pathway and how progress will depend on aligning biological innovation with appropriate clinical endpoints, regulatory frameworks and patient-centred outcomes.